- Home
- LLY
as 02-21-2025 4:00pm EST
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
| Founded: | 1876 | Country: | United States |
| Employees: | N/A | City: | INDIANAPOLIS |
| Market Cap: | 770.9B | IPO Year: | N/A |
| Target Price: | $985.00 | AVG Volume (30 days): | 3.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 21 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 11.71 | EPS Growth: | 101.90 |
| 52 Week Low/High: | $711.40 - $972.53 | Next Earning Date: | 02-06-2025 |
| Revenue: | $45,042,700,000 | Revenue Growth: | 32.00% |
| Revenue Growth (this year): | 32.76% | Revenue Growth (next year): | 17.58% |
Stock Insider Trading Activity of Eli Lilly and Company (LLY)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| LILLY ENDOWMENT INC | LLY | 10% Owner | Feb 6 '25 | Sell | $876.89 | 210,000 | $183,567,261.66 | 96,886,908 |
Latest Eli Lilly and Company News
LLY Breaking Stock News: Dive into LLY Ticker-Specific Updates for Smart Investing
Simply Wall St.
20 hours ago
Eli Lilly (NYSE:LLY) stock performs better than its underlying earnings growth over last five years
Motley Fool
20 hours ago
3 Magnificent Growth Stocks to Buy Right Now
Investor's Business Daily
a day ago
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage
Barrons.com
a day ago
Hims & Hers Stock Plummets. The Wegovy Shortage Is Over.
Investopedia
a day ago
Hims & Hers Stock Drops as FDA Says Ozempic and Wegovy No Longer in Short Supply
Quartz
2 days ago
The Ozempic shortage is over
Zacks
2 days ago
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Insider Monkey
2 days ago
Is Eli Lilly and Company (LLY) the Best Non-Tech Stock to Buy Now for Long Term?
Compare LLY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LLY Eli Lilly and Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.